Advertisement
ACT

MAR.7/2017


news roundup

Asia Returns to Trial Prominence

According to Frost & Sullivan, Asia is an increasingly attractive destination for biotechs because of large patient pools available and the lower cost of trials in most Asian countries.


advertisment

Expert advice and sought-after methods for managing today's most critical elements in clinical trial execution are waiting for you on the industry's first educational and training portal. Download white papers, thought leadership articles, and much more - all on Almac Clinical University.
Learn more


EMA, FDA Agree on Mutual Recognition Inspections

The EMA issued a release that it and the FDA will rely on each other's inspections of production sites of medicinal products to ensure compliance with Good Manufacturing Practice (GMP). In the future, the need for an EU authority to inspect a site located in the U.S., or vice versa, will be limited to exceptional circumstances.


advertisment

Improving Clinical Trial Transparency, Collaboration and Efficiencies
Live Webinar: Wednesday, March 29 at 11:00am EDT
Register now


NIH Extends PPD HIV Research Contract

PPD announced that it has renewed its contract with the Division of Aids, National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health (NIH).


Take the Clinical Endpoints Adjudication Survey!

The survey will evaluate how endpoint adjudication is impacting study design, and uncover operational challenges with endpoint adjudication and endpoint adjudication outcomes.


Where's the Brexit?

A government white paper released in early February laid out priority areas and goals for the two-year period of negotiation that will follow once Article 50 is triggered. This article examines potential Brexit effects on the pharmaceutical industry, in light of information presented in the white paper.

advertisment

In this edition

FDA Promotes Diversity in Clinical Trials
Where's the Brexit?
Measuring Adoption and Value of Patient Engagement

advertisment

Use Challenge Trials Effectively in Clinical Studies: Lessons Learned from H3N2 Influenza Virus
Live Webinar: Tuesday, March 28 at 3 pm CEST and Thursday, April 6 at 10 am EDT
Register now


Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »


advertisment

Are Local IRBs Really Necessary?
On Demand
Register now


Events

Imaging in Clinical Trials
3rd Annual Endpoint Adjudication
4th Annual eSource Data in Clinical Investigations Bootcamp
Search Upcoming Events

Articles

How Clinical Trials and Cold Chain Logistics Intertwine

A better understanding of the effects of refrigerants, temperature excursions and logistics effects on the quality of the product/material being shipped and the resultant clinical data is badly needed.


Measuring Adoption and Value of Patient Engagement

In his column, Ken Getz explores the adoption of patient engagement and discusses research that shows patient and professional advisory boards, social media engagement and patient education programs offered the highest return on engagement.

Blog Posts

FDA Promotes Diversity in Clinical Trials

The Drug Trials Snapshots summary report for 2015 and 2016 indicates that last year, women accounted for 48% of participants in studies for 22 important new drugs, up from 40% in studies supporting 45 new drugs in 2015.


Take the 2017 TMF Reference Survey Today!

All stakeholders – sites, inspectors, sponsors, CROs, and vendors - are welcome to take the non-commercial TMF Reference Model's state-of-the-industry 2017 TMF Survey, designed to provide insights for both paper and electronic trial document management.


Get the full picture

Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription


Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com

Advertise

Mike Tessalone
Publisher
Michael.Tessalone@ubm.com